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Abstract
Chemical pollutant exposure is a risk factor contributing to the growing epidemic of non-alcoholic fatty liver disease 
(NAFLD) affecting human populations that consume a western diet. Although it is recognized that intoxication by chemical 
pollutants can lead to NAFLD, there is limited information available regarding the mechanism by which typical environ-
mental levels of exposure can contribute to the onset of this disease. Here, we describe the alterations in gene expression 
profiles and metabolite levels in the human HepaRG liver cell line, a validated model for cellular steatosis, exposed to the 
polychlorinated biphenyl (PCB) 126, one of the most potent chemical pollutants that can induce NAFLD. Sparse partial least 
squares classification of the molecular profiles revealed that exposure to PCB 126 provoked a decrease in polyunsaturated 
fatty acids as well as an increase in sphingolipid levels, concomitant with a decrease in the activity of genes involved in lipid 
metabolism. This was associated with an increased oxidative stress reflected by marked disturbances in taurine metabolism. 
A gene ontology analysis showed hallmarks of an activation of the AhR receptor by dioxin-like compounds. These changes 
in metabolome and transcriptome profiles were observed even at the lowest concentration (100 pM) of PCB 126 tested. A 
decrease in docosatrienoate levels was the most sensitive biomarker. Overall, our integrated multi-omics analysis provides 
mechanistic insight into how this class of chemical pollutant can cause NAFLD. Our study lays the foundation for the devel-
opment of molecular signatures of toxic effects of chemicals causing fatty liver diseases to move away from a chemical risk 
assessment based on in vivo animal experiments.
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Introduction
A growing epidemic of non-alcoholic fatty liver disease 
(NAFLD) is affecting human populations that consume 
a western diet (Argyrou et al. 2017). The spectrum of 
NAFLD ranges from fatty infiltration of the liver (steato-
sis), to more advanced stages characterized by liver inflam-
mation and fibrosis (non-alcoholic steatohepatitis, NASH), 
and subsequent cirrhosis, and hepatocellular carcinoma 
(Michelotti et al. 2013; Vernon et al. 2011). NAFLD cur-
rently affects 25% of the US population, and approximately 
2–5% have NASH (Vernon et al. 2011) with concomitant 
massive clinical and economic burden (Younossi et al. 
2016). Annual direct medical costs have been estimated 
to be approximately $103 billion ($1613 per patient) in 
the US. The occurrence of NAFLD in Europe is also very 
high and ranges from 20 to 30% with annual medical costs 
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currently running at €35 billion (from €354 to €1163 per 
patient) in countries such as Germany, France, Italy, and 
the United Kingdom (Younossi et al. 2016). Risk factors 
identified to date for the development of NAFLD include 
being overweight or obese, having diabetes and high cho-
lesterol or high triglycerides in the blood. Rapid weight 
loss and poor eating habits can also lead to NAFLD. The 
heritability of NAFLD was estimated at ~ 50% (Sookoian 
and Pirola 2017). However, some individuals develop 
NAFLD even if they do not have any of these risk factors 
(Foulds et al. 2017) and with exposure to physiologically 
active environmental pollutants being a recognized addi-
tional determinant of disease establishment.
Chemical exposure has long been known to be a risk fac-
tor for NAFLD/NASH (Petrakis et al. 2017; Wahlang et al. 
2013), which is also known as toxicant-associated fatty liver 
disease (TAFLD) and its more severe form, toxicant-asso-
ciated steatohepatitis (TASH). TAFLD has been commonly 
associated with acute chemical exposures at the workplace 
(Cave et al. 2010b), or after industrial accidents (Yu et al. 
1997). However, there is also evidence showing that environ-
mental pollutants have the ability to cause TAFLD at envi-
ronmental levels of exposure (Cave et al. 2010a). The ability 
of environmental pollutants to disturb metabolic processes at 
low environmental levels of exposure generally results from 
their ability to interfere with the activity of natural hormones 
by binding to their receptors (Heindel et al. 2017). Differ-
ent structural classes of environmental pollutants have been 
shown to modulate liver nuclear receptors, such as dioxins 
acting on the aryl hydrocarbon receptor (AhR), organotins 
on peroxisome proliferator-activated receptor γ (PPARγ), 
or organochlorines on the constitutive androstane receptor 
(CAR) (Foulds et al. 2017). Some environmental pollutants 
also promote NAFLD because of their hormone mimicking 
properties on distant organs. For example, bisphenol A acts 
on the pancreas by stimulating the production and secre-
tion of insulin which, in turn, increases the storage of fat by 
stimulating lipogenesis in the liver (Fabricio et al. 2016). 
Commonly defined as obesogens, some other endocrine 
disrupting chemicals (EDCs) have been found to promote 
adipose cell differentiation and lipid accumulation (Jane-
sick and Blumberg 2016) with some studies establishing a 
direct link between human exposures to some EDCs and 
risk of obesity (Tang-Peronard et al. 2014). Recent advances 
in human microbial ecology has also revealed that altera-
tions of the gut microbiota by chemicals at early stages of 
life accelerate hepatic lipid metabolism (Ba et al. 2017). 
However, TAFLD is not only a hormone receptor-mediated 
disease but can also arise from metabolic imbalances. For 
instance, fatty acid breakdown can be altered following a 
direct inhibition of mitochondrial β-oxidation by, for exam-
ple, the insecticide chlordecone (Kaiser et al. 2012). Mito-
chondrial β-oxidation can also be indirectly inhibited by an 
alteration in NAD + cofactor metabolism by compounds 
such as vinyl chloride.
Overall, biological mechanisms underlying the develop-
ment of steatosis are grouped into four biological processes 
affecting the metabolism of fatty acids: an increased uptake, 
a decreased efflux, an increased synthesis, or defects in their 
oxidative metabolism (Angrish et al. 2017). All these pro-
cesses are interrelated with a need for more studies provid-
ing mechanistic insight into the alteration of hepatic lipid 
metabolism, which in turn induces the development of 
NAFLD (Foulds et al. 2017). This is a priority for regula-
tory toxicology programs and includes a move away from 
a chemical risk assessment based on in vivo animal experi-
ments (Merrick et al. 2015). This can be achieved by detailed 
molecular profiling studies describing the effects of known 
toxicants on validated tissue culture model systems, such 
as the human liver cell line HepaRG (Angrish et al. 2017).
We describe here the alterations in the gene expression 
profile and metabolite levels of HepaRG cells exposed to 
the polychlorinated biphenyl (PCB) congener 126, one of 
the most potent chemicals associated with development of 
TAFLD (Al-Eryani et al. 2015). Our investigation included 
a metabolomics analysis, which identified 802 metabolites, 
which were analyzed with MetExplore (Cottret et al. 2010), 
to extract the metabolic sub-network involved in the bio-
logical response to low environmental levels of PCB 126 
exposure. This was coupled with a transcriptomics analy-
sis allowing identification of gene networks involved in the 
response to PCB 126. Our study is the first in-depth investi-
gation of the molecular profiles underlying the toxic effects 
of PCB 126 by integrating the transcriptome and metabo-
lome of HepaRG cells in response to this compound and 
which ultimately highlighted TAFLD-associated sensitive 
biomarkers of exposure to this class of pollutant.
Materials and methods
Reagents
All reagents and chemicals, unless otherwise specified, 
were of analytical grade and were purchased from Sigma-
Aldrich (Gillingham, Dorset, UK). The PCB 126 (98.5% 
purity, CAS Number 57465-28-8) was purchased from 
LGC Standards GmbH (Wesel, Germany). Stock solu-
tions of PCB 126 were made by dissolving in DMSO. The 
Williams’E medium + GlutaMAX™ were purchased from 
Gibco (Thermo Fisher Scientific, Loughborough, UK). The 
supplement ADD670, as well as the DMSO, was provided 
by Biopredic International (Rennes, France).
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HepaRG cell culture
HepaRG™ cells (HPR 116) were purchased from Bio-
predic International (Rennes, France). Cells were thawed, 
suspended and plated in the general purpose medium 
(Williams’E medium + GlutaMAX™) containing the 
ADD670 supplement. A total of 72,000 and 2,000,000 cells 
were plated in collagen-coated 96-well plates (Greiner Bio-
One, Germany) and 6-well plates (Biopredic), respectively. 
All cells were cultured at 37 °C and a 5%  CO2 atmosphere. 
The medium was refreshed at days 2, 5 and 7 after initial 
plating. The cells were kept in the general purpose medium 
until day 8, when the culture becomes well organized and 
includes well-delineated trabeculae and many canaliculi-like 
structures. At this time, the culture is composed of primitive 
biliary epithelial cells and mature hepatocytes with basal 
metabolic activities similar to fresh hepatocyte cells. From 
day 8 to day 14, cells were switched to the test medium 
composed of Williams’ E medium + GlutaMAX™ supple-
mented with 2% fetal bovine serum (FBS; GE Healthcare 
Life Sciences, Buckinghamshire, UK), 2 mM l-glutamine 
(GE Healthcare Life Sciences), 10 μg/mL penicillin/strepto-
mycin (Life technologies) and 1% DMSO, as well as differ-
ent concentrations of PCB 126 or the solvent control. Effects 
of PCB 126 was assessed at three concentrations to cover 
a wide range of biological activities, starting from a low 
environmental concentration (100 pM) to a high concentra-
tion of (1 μM), with an intermediate concentration (10 nM).
Mass spectrometry‑based metabolomics
Approximately 5,000,000 cells per sample were harvested 
from the 6-well plate cultures to obtain a sufficient amount 
of material to perform the metabolomics analysis. Cells were 
detached using 0.05% trypsin EDTA (Thermo Fisher Scien-
tific, Loughborough, UK), and collected by centrifugation 
to eliminate trypsin residues and cell pellets frozen. The 
frozen cell pellets were then processed by Metabolon Inc. 
(Durham, NC, USA) for metabolomics analysis. Samples 
were prepared using the automated MicroLab STAR ® sys-
tem from Hamilton Company (Reno, NV, USA). Proteins 
were precipitated with methanol under vigorous shaking for 
2 min using the Glen Mills GenoGrinder 2000 (Glen Mills, 
NJ, USA) followed by centrifugation. Samples were placed 
briefly on a  TurboVap® (Zymark, Hopkinton, MA, USA) 
to remove the organic solvent. The sample extracts were 
stored overnight under nitrogen before preparation for analy-
sis. The resulting extract was analyzed on four independent 
instrument platforms: two different separate reverse-phase 
ultrahigh performance liquid chromatography–tandem mass 
spectroscopy analysis (RP/UPLC–MS/MS) with positive ion 
mode electrospray ionization (ESI), a RP/UPLC–MS/MS 
with negative ion mode ESI, as well as a by hydrophilic 
interaction chromatography (HILIC)/UPLC–MS/MS with 
negative ion mode ESI.
All UPLC–MS/MS methods utilized a Waters 
ACQUITY ultraperformance liquid chromatography 
(UPLC) (Waters Corporation, Milford, MA, USA) and 
a Thermo Scientific Q-Exactive high-resolution/accu-
rate mass spectrometer (Thermo Fisher Scientific Inc., 
Waltham, MA USA) interfaced with a heated electro-
spray ionization (HESI-II) source and Orbitrap mass 
analyzer operated at 35,000 mass resolution. The sample 
extract was dried then reconstituted in solvents compat-
ible to each of four methods used. Each reconstitution 
solvent contained a series of standards at fixed concen-
trations to ensure injection and chromatographic con-
sistency. One aliquot was analyzed using acidic positive 
ion conditions, chromatographically optimized for more 
hydrophilic compounds. In this method, the extract was 
gradient eluted from a C18 column (Waters UPLC BEH 
C18-2.1 × 100 mm, 1.7 µm) using water and methanol, 
containing 0.05% perfluoropentanoic acid (PFPA) and 
0.1% formic acid (FA). Another aliquot was also analyzed 
using acidic positive ion conditions, chromatographi-
cally optimized for more hydrophobic compounds. In this 
method, the extract was gradient eluted from the same 
aforementioned C18 column using methanol, acetonitrile, 
water, 0.05% PFPA and 0.01% FA, and was operated at an 
overall higher organic content. Another aliquot was ana-
lyzed using basic negative ion optimized conditions using 
a separate dedicated C18 column. The basic extracts were 
gradient eluted from the column using methanol and water, 
with 6.5 mM ammonium bicarbonate at pH 8. The fourth 
aliquot was analyzed via negative ionization following elu-
tion from a HILIC column (Waters UPLC BEH Amide 
2.1 × 150 mm, 1.7 µm) using a gradient consisting of water 
and acetonitrile with 10 mM ammonium formate, pH 10.8. 
The MS analysis alternated between MS and data-depend-
ent MSn scans using dynamic exclusion. The scan range 
varied slightly between methods but covered 70–1000 m/z.
Instrument variability was 5%. This was determined by 
calculating the median relative standard deviation (RSD) for 
the standards that were added to each sample prior to injec-
tion into the mass spectrometers. Overall process variability 
was 10%. This was determined by calculating the median 
RSD for all endogenous metabolites (that is, non-instrument 
standards) present in 100% of the pooled matrix samples.
Raw data were extracted, peak-identified and QC pro-
cessed using hardware and software of Metabolon Inc. Com-
pounds were identified by comparison with library entries of 
purified standards or recurrent unknown entities. Biochemi-
cal identifications are based on three criteria: retention index 
within a narrow retention time/index (RI) window of the 
proposed identification, accurate mass match to the library 
+/− 10 ppm, and the MS/MS forward and reverse scores 
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between the experimental data and authentic standards. 
While there may be similarities between these molecules 
based on one of these factors, the use of all three data points 
can be utilized to distinguish and differentiate biochemi-
cals. Peaks were quantified using the area-under-the-curve 
method.
RNA sequencing (RNA‑seq)
RNA extraction and double‑stranded cDNA library 
preparation
RNA extraction was performed using the Qiagen RNeasy 
kit (Qiagen, Manchester, UK) according to the manufac-
turer’s instructions. The samples were checked for RNA 
quality using the Agilent 2100 Bioanalyzer (Agilent Tech-
nologies UK Limited, Craven Arms, UK) and quantified 
using a Nanodrop instrument (ND-1000 Spectrophotome-
ter; Thermo Fisher Scientific Inc.). The extracted RNA was 
subsequently subjected to treatment with DNAse I (Thermo 
Fisher Scientific Cat. no: AM222) followed by purification 
with Agencourt Ampure XP beads (Thermo Fisher Scientific 
Cat. no: A63881). A 20 ng aliquot of intact high-quality total 
RNA (RIN > 9) from each sample was then used as input to 
generate libraries for RNA-seq using the NEBNext Ultra 
II Directional RNA kit (NEB, Hitchin Herts, UK; Cat. no: 
E7760S) following the manufacturer’s recommendations. 
This protocol involved an initial step of rRNA depletion, 
followed by fragmentation prior to first-strand cDNA syn-
thesis and barcoding of the second-strand cDNA synthe-
sised with indices for Illumina platform sequencing for final 
library amplification. The resulting libraries were assessed 
on the Bioanalyzer 2100 for purity. Sequencing of the result-
ant double-stranded (ds) cDNA libraries was performed by 
applying Illumina sequencing by synthesis technology.
Sequencing of ds‑cDNA libraries
Out of a total of 40 cDNA libraries generated, 15 were 
randomly selected and assessed for quality and fragment 
size distribution using the Agilent 2200 Tapestation (Agi-
lent Technologies UK Limited) prior to sequencing. All 
samples showed libraries of good quality, with minimal 
adapter-dimer contamination, and an average fragment size 
of 345 bp. All 40 libraries were quantified using the Qubit 
2.0 spectrophotometer and the high-sensitivity dsDNA 
Qubit reagent kit (Life Technologies, Thermo Fisher Sci-
entific, Loughborough, UK). An equimolar quantity of 
each library was pooled for sequencing, and the resulting 
complete pool was quality checked using the Agilent 2200 
Tapestation. Sequencing consisted of generating 75-bp 
paired-end reads for the final pool of 40 libraries using the 
Illumina  NextSeq®500 instrument in conjunction with the 
 NextSeq®500 v2 High-output 150-cycle kit (Illumina Inc., 
Cambridge, UK).
Statistical analysis
The metabolome data analysis was performed using Metabo-
Analyst 3.0 (Xia and Wishart 2016). We removed variables 
with more than 50% of missing values. We also replaced 
remaining missing values with a small value (half of the 
minimum positive values in the original data) assuming to 
be the detection limit. Furthermore, variables that show low 
repeatability as measured using the relative standard devia-
tion were removed. This step is recommended for untargeted 
metabolomics datasets with a large number of variables to 
remove baseline noise (Hackstadt and Hess 2009). Data were 
then median scaled, log transformed, and normalized to pro-
tein concentration, as determined using the Bradford rea-
gent, from the cell pellets. A principal component analysis 
(PCA) was first performed to inspect the data variance and 
see how the samples are related to each other. This was then 
followed by an orthogonal projection to latent structures 
discriminant analysis (OPLS-DA) to identify the source of 
variation between control and treated groups (Worley and 
Powers 2016). OPLS-DA is an extension of the PLS-DA 
method, which incorporates an orthogonal component dis-
tinguishing the variability corresponding to the experimental 
perturbation (here the effect of PCB 126) from the portion 
of the data which is orthogonal, that is, independent from 
the experimental perturbation. Although PCA is an unsuper-
vised method, the OPLS-DA is supervised. The separation 
between the different classes is calculated by maximizing 
the covariance between the metabolome matrix (x) and the 
experimental group labels (y). It is thus prone to overfitting, 
which we addressed by performing permutation testing. Sta-
tistically significant alterations in the levels of metabolites 
were identified based on the significance after analysis with 
a one-way ANOVA test adjusted for multiple comparisons 
with Fisher’s least significant difference (q < 0.05). The 
metabolome network visualization was performed with 
MetExplore as described (Cottret et al. 2010). Briefly, the 
sub-network was obtained by keeping reactions belong-
ing to shortest paths up to a length of 4 between pairs of 
metabolites in the fingerprint. Network was modelled based 
on Recon2 (Thiele et al. 2013) human metabolic network 
using atom conservation graph (Frainay and Jourdan 2017) 
where two metabolites are connected if they are substrate 
and product of the same reaction and share at least one car-
bon (excluding carbon dioxide from the network).
The RNA-seq data analysis was performed using the 
latest version of the Tuxedo protocol with HISAT, String-
Tie and Ballgown (Pertea et al. 2016). First, we analyzed 
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the quality scores and other metrics using FASTQC 
(Andrews 2010). Contamination from rRNA was measured 
by aligning the sequences of human rRNA to the FASTQ 
files (http://genom espot .blogs pot.co.uk/2015/08/scree 
n-for-rrna-conta minat ion-in-rna.html). Sequences were 
then aligned to the human genome (Supplementary File 
1) using the hierarchical indexing for spliced alignment 
of transcripts program HISAT2 (Kim et al. 2015). For this 
purpose, we used prebuilt indexes (H. sapiens, GRCh38) 
downloaded from the HISAT2 website. Alignment rates 
ranged from 85.12 to 95.53% (average of 91.63%). The 
number of reads per samples ranged from 9,467,558 to 
35,623,876 (average of 21,575,770 reads). Then, StringTie 
was used to assemble and quantify the transcripts in each 
sample using the Homo_sapiens.GRCh38.89 database 
(Pertea et al. 2016). Finally, the differential gene expres-
sion analysis was made with Ballgown (Frazee et al. 2015) 
in R environment (Team 2017). Low abundance transcripts 
with a variance across samples of less than one were fil-
tered. A standard linear model-based comparison of tran-
script abundance was performed without adjusting for 
other covariates to identify differentially expressed tran-
scripts (q < 0.05).
Functional implications of the alteration in gene expres-
sion profiles were analyzed using ClueGO (Bindea et al. 
2009) and CluePedia plugins in Cytoscape (version 3.5.1) 
(Shannon et al. 2003). The GO biological process data-
base (23.02.2017) and the KEGG annotation database 
(01.03.2017) were used. The analysis was conducted using 
a two-sided hypergeometric test for enrichment using a p 
value threshold of 0.05 after its adjustment by the Ben-
jamini–Hochberg procedure (Benjamini and Hochberg 
1995). GO term fusion was employed to integrate GO 
categories, minimize the output, and create a functionally 
organized GO category network. Our network displayed 
GO terms found in the levels 5–10 of the GO hierarchy, to 
avoid meaningless high-level hierarchy terms. Since it is 
well known that gene-annotation enrichment tools can give 
different results, we corroborated our interpretations by 
undertaking an additional KEGG functional analysis using 
the Wallenius non-central hypergeometric distribution in 
the Bioconductor package GOSeq (Young et al. 2010). 
This analysis has the advantage of correcting for the 
gene selection bias due to differences in transcript length 
present in RNA-seq datasets. KEGG annotation enrich-
ment profiles were found to be very similar to the results 
obtained with ClueGO. These RNA-seq data have been 
submitted to Gene Omnibus and are accessible through 
accession number GSE109565.
The metabolome and transcriptome datasets were then 
integrated by a sparse partial least squares regression (sPLS) 
performed with the MixOmics package. PLS is a super-
vised method, which selects correlated variables (genes, 
metabolites) across the same samples by maximizing the 
covariance between the datasets. The sparse version of PLS 
(sPLS) was used to select the most correlated variables 
using LASSO penalization on the pair of loading vectors as 
described by Le Cao et al. (2008).
Results
We determined transcriptome and metabolome signatures of 
the effect of a 6-day exposure to PCB 126 in differentiated 
HepaRG human liver cells (Fig. 1). The cells presented no 
visible signs of aging, or phenotypic alterations caused by 
PCB 126, at the time point used to evaluate effects. This 
was verified by measuring lipid accumulation using the Adi-
poRed assay (Supplementary File 5). PCB 126 treatment of 
HepaRG cells gave rise to a non-significant increase in lipid 
accumulation at the two lowest concentrations (100 pM, 
10 nM) tested. This validates our approach since the first 
aim of our experiments was to identify the primary effects 
of PCB 126 and not secondary effects due to the accumula-
tion of lipids.
Fig. 1  Morphology of HepaRG cells. After undergoing a complete 
programme of hepatocyte differentiation, HepaRG cells display the 
phenotype reflective of normal human liver cells including binuclear 
hepatocytes and forming bile canaliculus-like structures. A mixed 
population of two types of cells is visible, namely, hepatocyte-like 
colonies (H) surrounded by clear epithelial cells corresponding to 
primitive biliary cells (B)
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Metabolomics analysis
The metabolome platform detected 802 metabolites. We 
removed 7 variables with more than 50% missing values, 
and 199 variables that showed low repeatability. The effects 
of the PCB 126 were first visualized by plotting each sample 
as a point in space defined by the two principal components 
from a PCA, to reduce the 596-dimensional space defined 
by the variations in the metabolites levels (Fig. 2a). The 
components separated the group of samples treated with 
the PCB 126 from the control group. As the dose of PCB 
126 increases, the groups become more clustered. We then 
built an OPLS-DA model (Fig. 2b) on the basis of the PCA 
results. The OPLS-DA model for PCB 126 (R2X = 0.177, 
Fig. 2  Multivariate analysis of HepaRG cell metabolome follow-
ing treatment with PCB 126 shows alterations in lipid metabolism. 
a Principal component analysis of metabolome profiles separate the 
group of samples treated with the PCB126 from the control group. 
As the dose of PCB 126 increases, the groups become more clus-
tered. b Orthogonal projection to latent structures discriminant 
analysis (OPLS-DA) properly classified all samples (R2X = 0.177, 
R2Y = 0.769, and Q2 = 0.58). The 95% confidence regions are dis-
played by shaded ellipses. c A 1000-time permutation test shows 
that the observed statistics is not part of the distribution formed by 
the statistics from the permuted data (R2Y p = 0.022; Q2 p < 0.001). 
d Cross-validation parameters, R2 and Q2, representing the qual-
ity of the model. e The S-plot visualizes the variable influence in 
the OPLS-DA model. Significantly disturbed metabolites towards 
the separation in OPLS-DA models (red dots) were selected based 
on the significance threshold of q < 0.05 after analysis with one-way 
ANOVA test adjusted for multiple comparisons with Fisher’s least 
significant difference. A total of 30 metabolites had their levels dis-
turbed by the PCB 126 treatments
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R2Y = 0.769, and Q2 = 0.58) appropriately classified all 
samples (Fig. 2d). This model explains 17.7% of the varia-
tion in metabolite levels (R2X) and 76.9% of the variations 
between the different groups (R2Y). The average prediction 
capability (Q2) was 58%. The difference between R2Y and 
Q2 was less than 0.2 and the Q2 value was greater than 
50%, revealing an excellent predictive capability (Robotti 
and Marengo 2016). A 1000-time permutation test was con-
ducted to further validate the OPLS-DA model (Fig. 2c). The 
empirical p values for R2Y (p = 0.022) and Q2 (p < 0.001) 
indicate that the observed statistic (based on our data) is not 
part of the distribution formed by those from the permuted 
data. Thus, the dose-dependent clustering of the data is sta-
tistically significant.
An S-plot was then constructed to visualize the loading 
of the PCB 126 OPLS-DA model (Fig. 2e), and determine 
which variables are the best discriminators between the dif-
ferent treatment groups. This plot combines the modelled 
covariance (p1) and the modelled correlation (p(corr)) from 
the OPLS-DA model in a scatter plot. The highest mag-
nitude and reliability scores were attributable to polyun-
saturated fatty acids (docosatrienoate 22:3n3 and 22:3n6) 
and ceramides. However, because OPLS-DA loading is dif-
ficult to interpret with more than two classes, we used the 
OPLS-DA method for score overview but for significantly 
disturbed metabolites (red dots, Fig. 2e) selected based on 
the results of a one-way ANOVA test. A total of 30 metabo-
lites had their levels disturbed by the PCB 126 treatments 
(Table 1). Most of the changes were dose dependent (Fig. 3). 
The most pronounced metabolic differences were attributed 
to a change in lipid metabolism. A total of four glycosyl-
ceramides and three glycosyl-sphingosines had their levels 
Table 1  Metabolome disturbances provoked by exposure to PCB 126 in HepaRG cells
All the metabolites displayed have their levels significantly altered (q < 0.05) after analysis with one-way ANOVA test adjusted for multiple com-
parisons with Fisher’s least significant difference
Biochemical Super_pathway Sub_pathway
Pyroglutamine Amino acid Glutamate metabolism
Betaine Amino acid Glycine, serine and threonine metabolism
Betaine aldehyde Amino acid Glycine, serine and threonine metabolism
Cysteine sulfinic acid Amino acid Methionine, cysteine, SAM and taurine metabolism
Hypotaurine Amino acid Methionine, cysteine, SAM and taurine metabolism
N-Acetylmethionine sulfoxide Amino acid Methionine, cysteine, SAM and taurine metabolism
Taurine Amino acid Methionine, cysteine, SAM and taurine metabolism
Kynurenine Amino acid Tryptophan metabolism
Picolinate Amino acid Tryptophan metabolism
5-Methyltetrahydrofolate (5MeTHF) Cofactors and vitamins Folate metabolism
Bilirubin (Z,Z) Cofactors and vitamins Hemoglobin and porphyrin metabolism
Biliverdin Cofactors and vitamins Hemoglobin and porphyrin metabolism
Glycosyl ceramide (d16:1/24:1, d18:1/22:1) Lipid Ceramides
Glycosyl ceramide (d18:1/20:0, d16:1/22:0) Lipid Ceramides
Glycosyl ceramide (d18:1/23:1, d17:1/24:1) Lipid Ceramides
Glycosyl ceramide (d18:2/24:1, d18:1/24:2) Lipid Ceramides
Glycosyl-N-behenoyl-sphingadienine (d18:2/22:0) Lipid Ceramides
Glycosyl-N-palmitoyl-sphingosine (d18:1/16:0) Lipid Ceramides
Glycosyl-N-stearoyl-sphingosine (d18:1/18:0) Lipid Ceramides
Oleoyl-oleoyl-glycerol (18:1/18:1) Lipid Diacylglycerol
N-Oleoyl taurine Lipid Endocannabinoid
Arachidonoyl carnitine (C20:4) Lipid Fatty acid metabolism (acyl carnitine)
1-Palmitoleoylglycerol (16:1) Lipid Monoacylglycerol
Glycerophosphoethanolamine Lipid Phospholipid metabolism
Docosatrienoate (22:3n3) Lipid Polyunsaturated fatty acid (n3 and n6)
Docosatrienoate (22:3n6) Lipid Polyunsaturated fatty acid (n3 and n6)
Sphingomyelin (d18:1/21:0, d17:1/22:0, d16:1/23:0) Lipid Sphingolipid metabolism
Asparaginyl valine Peptide Dipeptide
Lysylserine Peptide Dipeptide
Serylglutamate Peptide Dipeptide
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increased [fold change (FC) up to 13.2 for glycosyl ceramide 
d181/231, d171/241], while polyunsaturated fatty acids such 
as docosatrienoate 22:3n3 (FC ranging from − 1.3 to − 5.4), 
and docosatrienoate 22:3n6 (FC from − 1.6 to − 6.5) and 
1-palmitoleoylglycerol (FC from − 1.8 to − 370) had their 
levels decreased. These lipids are common constituents of 
cell membranes, and thus changes in their levels suggest that 
membrane integrity and maintenance is adversely affected 
by the PCB 126 treatment.
Our results also show an increased activity within 
detoxification pathways. Multiple metabolites, including 
cysteine sulfinic acid, taurine, hypotaurine, N-oleoyltau-
rine, and N-acetylmethionine sulfoxide are significantly 
elevated in a dose-dependent manner. The predominant 
Fig. 3  Box plot of metabolome changes associated with the expo-
sure to PCB 126 to HepaRG cells shows a dose-dependent effect. 
All the metabolites displayed have their levels significantly altered 
(q < 0.05) after analysis with one-way ANOVA test adjusted for mul-
tiple comparisons with Fisher’s least significant difference. Most of 
the changes caused by the PCB treatment were dose dependent
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pathway elicited as a response to oxidative stress seems to 
be taurine metabolism as indicated by the network analy-
sis performed using MetExplore (Fig. 4a). Our network 
analysis reveals that bilirubin and biliverdin are further 
away from most metabolites in the fingerprint (Fig. 4b). 
Thus, the network extraction focused on the first cluster 
which contains more metabolites (Fig. 4a). The core part 
of the taurine and hypotaurine metabolism seems to be 
modulated (disregarding bilirubin and biliverdin) as a 
consequence of the oxidative stress induced by PCB 126.
Multiple gamma-glutamyl amino acids such as gamma-
glutamylglutamine and gamma-glutamylcysteine are also 
elevated. This is possibly in response to oxidative stress 
being caused by the PCB 126 exposure. Several activators 
of aryl hydrocarbon receptor (AhR)-mediated transcription 
such as the bile pigments biliverdin and bilirubin, as well as 
tryptophan metabolites kynurenine and picolinate, had their 
levels decreased by the PCB 126 treatment. Other intermedi-
ates in tryptophan metabolism such as quinolinate, kynure-
nate and pyridoxate were also decreased but did not reach 
statistical significance.
Transcriptomics analysis
Transcriptome profiles of HepaRG cells were then analyzed 
using Illumina-based RNA sequencing. An unsupervised 
visualization of the variance structure by a PCA showed 
comparable results to those of the metabolome profiles. The 
control group separates from the PCB 126 groups in a dose-
dependent manner on the second component (Fig. 5). The 
source of variation causing the clustering on the first com-
ponent remains unknown as no batch effects was identified 
Fig. 4  Network analysis of metabolome profile alterations demon-
strates a role of taurine and hypotaurine in oxidative stress induced 
by PCB 126 in HepaRG cells. a Sub-network. Circles are metabolites 
and rectangles are reactions. Reaction labels are EC numbers and 
metabolite names are from Recon2 model. Red circle metabolites are 
the ones from the fingerprint. b Distance matrix between metabolites 
belonging to the network. Red corresponds to shorter distance (0) and 
white to longer distances (12 reactions between nodes)
Fig. 5  Principal component analysis of transcriptome profile altera-
tions provoked by exposure of HepaRG cells to PCB 126. Transcript 
abundances were assessed using Stringtie. The PCA was performed 
using log2 transformed FPKM measurements of transcripts across 
samples assessed with Ballgown. The groups become more clustered 
as the dose of PCB 126 increases. The 95% confidence regions are 
displayed by ellipses
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in the experimental procedure. As a result, the standard lin-
ear model-based comparison of transcript abundance was 
performed without adjusting for other covariates. A total of 
264 transcripts had their levels altered by the PCB 126. We 
present a detailed analysis of CYP1A1 expression as a rep-
resentative of the changes we observed (Fig. 6). CYP1A1 is 
known to be highly expressed following exposure to dioxins 
and PCBs as its promoter contains seven dioxin-responsive 
elements, which bind the aryl hydrocarbon receptor (Li 
et al. 2014). The evaluation of expression levels among 12 
distinct isoforms of CYP1A1 shows that some transcripts 
are expressed at a much higher level than others (Fig. 6a). 
Four of these 12 isoforms had their expression increased 
from the lowest concentration (q < 0.05). A scatter plot of 
the expression levels for the 24 most differentially expressed 
transcripts shows that alterations were dose dependent and 
Fig. 6  Differential CYP1A1 expression analysis using RNA-seq in 
HepaRG cells exposed to three concentrations of PCB 126. a Struc-
ture and expression levels of 12 distinct isoforms of CYP1A1 across 
the different treatment groups. Differences in expression levels are 
displayed in varying shades of yellow. The ENST00000395048 iso-
form of CYP1A1 is expressed at a much higher level than the others, 
as indicated by the dark orange color. b FPKM distributions of four 
CYP1A1 transcripts displayed as box-and-whiskers plots. All four iso-
forms have their expression significantly altered (q < 0.05) by expo-
sure to PCB 126 as measured by a standard linear model-based com-
parison in Ballgown
Fig. 7  Pathway enrichment 
analysis in the transcriptome 
of HepaRG cells exposed to 
PCB 126 shows an activation 
of xenobiotic metabolism by 
dioxin-like compounds. Gene 
functions were studied using 
ClueGO and CluePedia plugins 
in Cytoscape (version 3.5.1). 
The analysis was conducted 
using a two-sided hypergeomet-
ric test for enrichment using a p 
value threshold of 0.05 after its 
adjustment by the Benjamini–
Hochberg procedure
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detectable at concentrations as low as 100 pM (Supplemen-
tary File 2).
We then performed a gene-annotation enrichment 
analysis to determine the biological processes affected 
by the exposure to PCB 126 (Fig. 7, Supplementary File 
3). Unsurprisingly, the most important networks affected 
by PCB 126 were related to the metabolism of xenobiot-
ics by P450 cytochromes (CYP1A1, CYP1A2, CYP1B1) 
and UDP glucuronosyltransferase (UGT1A1, UGT1A3, 
UGT2A3, UGT2B11), both being well-known PCB met-
abolic pathways. In addition, the activity of the aldehyde 
dehydrogenases (ALDH1A3, ALDH3A1), which catalyze 
oxidation of aromatic aldehydes produced by-products of 
mono-oxygenation reactions, were also upregulated. These 
are all hallmarks of an activation of xenobiotic metabolism 
by dioxin-like compounds (Grimm et al. 2015). However, 
surprisingly genes involved in the glycosaminoglycan met-
abolic process were the most enriched category (AP2A1, 
CEMIP, CHSY1, FUCA1, GALNT5, GPC6, LUM). This 
can reflect an increase in glucuronidation metabolism as 
the UGT group of enzymes are central players in glycosyla-
tion processes. Perhaps one of the most surprising enriched 
pathways were the systemic lupus erythematosus (SLE) 
KEGG pathway containing histone genes (C5, H2AFV, 
HIST1H2AB, HIST1H2AE, HIST1H2AG, HIST1H2BO). 
The genes for the AGE-RAGE signalling pathway associated 
with diabetic complications (AGTR1, CDKN1B, COL3A1, 
MMP2, PRKCA, SERPINE1) were also enriched. The same 
genes are found in the HIF-1 signalling pathway, which was 
also enriched. Taken together, these results point to a role 
of hypoxia in the toxic effects generated by the exposure to 
PCB 126.
We then integrated the results from the transcriptome and 
the metabolome by performing a sPLS analysis, with two 
components being sufficient to model the data (Q2 of 0.1 
and 0.17). The performance of the sPLS analysis was weak 
because of the relatively small number of samples. However, 
the different groups were well separated (Fig. 8a), with the 
samples from the two highest concentrations of PCB 126 
treatments being clustered together and separate from the 
control and the lowest dose samples. We then investigated 
the correlation between variables (Fig. 8b, c). Sphingolipids 
and polyunsaturated fatty acids (PUFA) were negatively and 
positively correlated, respectively, with the expression of 
genes involved in triglyceride metabolism (such as APOA2, 
CPS1, HMGCS2, LPL). That is, the decrease in PUFA lev-
els, as well as the increase in sphingolipid levels, is con-
comitant to a decrease in the activity of genes involved in 
lipid metabolism.
Discussion
With the steadily increasing number of synthetic chemicals 
being released in the environment, the ability to use human 
cell lines to evaluate toxicity of pollutants and move away 
from more time-consuming and expensive risk assessment 
based on in vivo animal experiments, has become one of the 
challenges of the twenty-first century (Hartung 2009). We 
present here an in-depth investigation of the toxic effects of 
the PCB 126, a model chemical for the induction of TAFLD, 
on the transcriptome and metabolome of human liver Hep-
aRG cells (Merrick et al. 2015; Mueller et al. 2014). We 
envisage that our investigation would be particularly use-
ful for the establishment of high-throughput assays using 
the HepaRG cell line, which has been found to be a good 
model system to predict the results of acute and repeated 
dose toxicity (Mueller et al. 2014) and to study human xeno-
biotic metabolism (Guillouzo et al. 2007). HepaRG is one 
of the best characterized liver cell lines. The most recent 
application of metabolomics analytical methods on HepaRG 
cells reported coverage of 2200 metabolites (Cuykx et al. 
2017). HepaRG cells are also metabolically competent and 
more stable than other hepatic cell lines, producing more 
reproducible data than primary human hepatocytes (Guil-
louzo et al. 2007). They are thus a reliable system to obtain 
information on networks of pathways adversely affected by 
pollutants that could lead to hepatic steatosis (Angrish et al. 
2017).
Our study provides interesting insights into the develop-
ment of sensitive biomarkers for TASH development. The 
most significant effect of PCB 126 exposure was a decrease 
in free long-chain fatty acids (LCFAs) and PUFAs. Our 
results show that docosatrienoate 22:3n3 and 22:3n6 are the 
most sensitive biomarkers of lipid metabolism disturbances 
in HepaRG cells (Fig. 1). This is in accord with the results 
obtained from a birth cohort from a fishing community 
that linked a high seafood intake, and thus high PCB expo-
sure, to alterations in lipid profiles (Grandjean and Weihe 
2003). Other experimental studies suggest that PCBs may 
affect the utilization of PUFAs by inhibition of Δ5- and 
Δ6-desaturation (Matsusue et al. 1999). Such enzyme inhi-
bition in fishing communities lead to deficient formation of 
arachidonic acid from its precursor, linoleic acid, attenuating 
the beneficial effects of essential lipids contained in seafood 
(Grandjean and Weihe 2003).
The analysis of gene expression profiles revealed altera-
tions in pathways reflecting PCB-induced metabolic diseases 
such as the activation of xenobiotic metabolism by dioxin-
like compounds. This can guide the development of gene 
expression biomarkers, which have been advocated by the 
US Environmental Protection Agency (EPA) as promising 
tools to reduce the cost and time of toxicity testing (EPA 
2544 Archives of Toxicology (2018) 92:2533–2547
1 3
2015), such as for the detection of potential EDCs acting 
as estrogen receptor agonists (Mesnage et al. 2017). Other 
projects have implemented online tools to provide an easy 
access to gene expression signatures allowing the detection 
of novel associations between genes, diseases and drugs 
(Wang et al. 2016). We provide here putative biomarkers 
of metabolic disturbances induced by PCB 126, which are 
known to correlate with the mechanisms by which this 
class of pollutants induce TASH (Al-Eryani et al. 2015). 
The expected hallmarks of an activation of xenobiotic 
metabolism by dioxin-like compounds were detected in the 
molecular profiles of HepaRG cells exposed to the PCB 
126 (Fig. 7). A limitation of this study is that the changes 
induced by the PCB 126 were measured at a late time point 
and may not reflect the first wave of transcriptional changes 
induced by this compound.
Other pathways altered in our study correlate with other 
less well-known health effects of PCB compounds. For 
instance, the SLE KEGG pathway was one of the most 
altered. This in all likelihood is not coincidental as the expo-
sure to PCBs has been linked to an increased incidence of 
SLE (Kamen 2014). Histone gene expression was the most 
Fig. 8  Sparse partial least squares regression (sPLS) integration of 
the metabolome and transcriptome profiles of HepaRG cells exposed 
to PCB 126 shows that alteration in sphingolipid levels is concomi-
tant to a decrease in the activity of genes involved in lipid metabo-
lism. a Individual plots displaying the covariance between the metab-
olome and the transcriptome datasets. b The variables selected by the 
sPLS are projected on a correlation circle plot to display the clusters 
of correlated variables. In this plot, the angle defined by the coordi-
nates of the variables on the axis defined by the components give an 
indication on the nature of the correlation. If the angle is sharp and 
the variables cluster together, the correlation is positive. If the angle 
is obtuse and the variables are not clustered together, the variables 
are negatively correlated. Perpendicular angles represent uncorrelated 
variables. c A clustered image map visualizes correlations between 
the metabolites and the genes by a color gradient on a two-dimen-
sional colored image. The negatively correlated variables (blue) are 
represented along the positively correlated variables (red). Dendro-
grams are added to represent the clusters produced by the hierarchical 
clustering
2545Archives of Toxicology (2018) 92:2533–2547 
1 3
disturbed of the SLE pathways in our study (Supplementary 
Material 3). This correlates with the fact that patients with 
SLE often carry anti-histone antibodies (Sun et al. 2008). 
A link with SLE is further corroborated by laboratory 
experiments showing that docosahexaenoic acid consump-
tion attenuates the autoimmune response in a mouse model 
of SLE (Bates et al. 2016). Another autoimmune disease 
observed with higher levels of PCB and organochlorine 
pesticide residue exposure is amyotrophic lateral sclerosis 
(ALS), which was detected in a case–control study measur-
ing chemical pollutants in the cerebrospinal fluid of 38 ALS 
patients and 38 control individuals (Vinceti et al. 2017). It 
may be argued that the detection of this gene expression sig-
nature in a hepatic cell line is of no direct relevance to SLE. 
This signature could be an artefact due to the limitations of 
gene ontology analysis, which could give different results 
depending on the software, its parameters, and the nucleic 
acid sequencing technology employed (Timmons et  al. 
2015). However, comparable responses have been found in 
other cell types equipped with AhR signalling (Vorrink et al. 
2014). Another category of genes whose levels we found 
altered were those involved in the glycosaminoglycan meta-
bolic process. This correlates with findings obtained from 
the analysis of the gene ontology enrichment in peripheral 
blood mononuclear cells of children chronically exposed to 
PCBs (Dutta et al. 2012). Generally, it is not surprising that 
we found alterations in gene expression pathways related to 
neurological processes since PCBs are known neurotoxic 
compounds with a gene–environment interaction capability 
(Docea et al. 2017; Ribas-Fito et al. 2001).
Our study also provides mechanistic insights into pertur-
bations provoked by very low environmental concentrations 
of PCB 126. Although the exposure to persistent organic 
pollutants such as PCBs is decreasing over time as they are 
progressively being banned, they are still found in human 
tissue at levels capable of causing pathologies. PCB 126 was 
found at concentrations of 209 and 80.4 ng/kg in the breast 
milk of Inuit and Caucasian women, respectively, in a survey 
performed in 1989–1990 (Dewailly et al. 1994). The analysis 
of the National Health and Nutrition Examination Survey 
(NHANES) data (1999–2002) reveals associations between 
PCB serum levels and adverse cognitive effects in older US 
adults (Przybyla et al. 2017). In more recent biomonitoring 
surveys, PCB 126 was found at a mean concentration of 
6.5 μg/L in umbilical cord serum of populations living near 
waste dump sites in Italy (Grumetto et al. 2015).
Although our study provides extensive insight into the 
mechanisms of toxicity of a single molecule, the human pop-
ulation is never exposed to single compounds but to complex 
mixtures (Hernandez et al. 2013). These complex effects 
cannot be assessed within the current research framework 
and new methodologies are urgently needed (Tsatsakis et al. 
2017). It is generally considered that the effects of chemical 
mixtures that act as AhR agonists can be approximately 
deduced using additive mathematical models (Brenerova 
et al. 2016). Although it can be assumed that the effects 
detected in this study may not be specific to PCB 126 but 
generalizable to other AhR agonists, it should be noted that 
some non-dioxin-like PCB congeners cause non-additive 
effects by altering AhR activation by PCB mixtures (Bren-
erova et al. 2016).
The transcriptome and metabolome signatures that we 
have identified in response to PCB 126 in HepaRG cells are 
likely to be similar to what occurs in cases of NAFLD caused 
by other factors. It is known from metabolome profiles that 
hepatic PUFAs are lower in NAFLD patients (Arendt et al. 
2015). This suggests that the exposure to environmental pol-
lutants could also be an aggravating factor in the develop-
ment of NAFLD, amplifying the effects of over-nutrition or 
a sedentary lifestyle. It has been proposed that PCB exposure 
can act as a second hit in NAFLD, driving progression of 
steatosis to NASH as has been found in laboratory animals 
exposed to PCB and a high-fat diet (Wahlang et al. 2014).
Conclusion
Although it is recognized that occupational exposures to 
chemical pollutants can lead to NAFLD, there is limited 
information available regarding the mechanism by which 
typical environmental levels of exposure can contribute 
to the onset of this disease. Importantly, the alterations 
in metabolome and transcriptome profiles in response to 
PCB 126 were observed even at the lowest concentration 
(100 pM) tested corresponding to what may be found in 
humans. Overall, our integrated multi-omics analysis pro-
vides mechanistic insight into how this class of chemical 
pollutant can cause NAFLD as demonstrated in other studies 
(Al-Eryani et al. 2015). In addition, we confirm the HepaRG 
cell line as a reliable model for molecular profiling inves-
tigations of TAFLD. Metabolome profiling reveals docosa-
trienoate levels as the most reliable marker of the exposure 
to PCB 126. Hallmarks of activation of the AhR receptor by 
dioxin-like compounds were detected in the transcriptome 
profiles. Our study provides the foundation for the develop-
ment of molecular signatures of fatty liver diseases to rapidly 
assess chronic toxic effects from exposure to compounds 
having a direct effect on the liver in a reliable hepatotoxic-
ity model system. The availability of such an in vitro model 
system will lessen the burden of chemical risk assessment 
based on in vivo animal experiments.
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